First Tracks Biotherapeutics (TRAX) Stock Price, News & Analysis
Company Description
First Tracks Biotherapeutics (NASDAQ: TRAX) is classified in the biotechnology industry within the Pharmaceutical Preparations sector and carries a market capitalization of $1.5B, ranking #2,724 among all listed U.S. companies by market cap.
This page collects what Stock Titan holds for TRAX, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
First Tracks Biotherapeutics (TRAX) stock last closed at $41.85. At a market capitalization of $1.5B, TRAX is classified as a small-cap stock with approximately 34.9M shares outstanding.
Latest News
First Tracks Biotherapeutics has 3 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 1 with negative movement. Key topics include conferences, earnings. View all TRAX news →
SEC Filings
First Tracks Biotherapeutics has filed 5 recent SEC filings, including 3 Form 4, 1 Form SCHEDULE 13G, 1 Form 8-K. The most recent filing was submitted on July 28, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all TRAX SEC filings →
Financial Highlights
Upcoming Events
ANB033 celiac top-line data
ANB033 EoE top-line data
First Tracks Biotherapeutics has 2 upcoming scheduled events. The next event, "ANB033 celiac top-line data", is scheduled for October 1, 2026 (in 63 days). Investors can track these dates to stay informed about potential catalysts that may affect the TRAX stock price.
Short Interest History
Short interest in First Tracks Biotherapeutics (TRAX) currently stands at 4.8 million shares, up 22.0% from the previous reporting period, representing 14.6% of the float. Since April 2026, short interest has increased by 18.4%. This moderate level of short interest indicates notable bearish positioning.
Days to Cover History
Days to cover for First Tracks Biotherapeutics (TRAX) currently stands at 4.2 days, down 12.3% from the previous period. This days-to-cover ratio represents a balanced liquidity scenario for short positions. The days to cover has decreased 44.1% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 4.2 to 10.4 days.
TRAX Company Profile & Sector Positioning
First Tracks Biotherapeutics (TRAX) operates in the Biotechnology industry within the broader Pharmaceutical Preparations sector and is listed on the NASDAQ. In monthly performance, the stock ranks #5 among all tracked companies.